Resveratrol alleviates non-alcoholic fatty liver disease through epigenetic modification of the Nrf2 signaling pathway

Authors

Keywords

Journal

Volume 119, Issue -, Pages 105667

Publisher

Elsevier BV

Online

2019-12-13

DOI

10.1016/j.biocel.2019.105667

Discuss science. Find collaborators. Network.

Join a conversation

Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.

Upload Now